Occult Breast Carcinoma Presenting as Scalp Metastasis
暂无分享,去创建一个
[1] H. Rugo,et al. Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis , 2017, Breast Cancer Research and Treatment.
[2] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[3] R. Stelini,et al. Cutaneous metastasis as the first manifestation of occult malignant breast neoplasia* , 2016, Anais brasileiros de dermatologia.
[4] Markku Miettinen,et al. GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors , 2014, The American journal of surgical pathology.
[5] S. Dry,et al. Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier , 2012, Clinical Cancer Research.
[6] Yasuhiro Fujiwara,et al. Immunohistochemical Profile for Unknown Primary Adenocarcinoma , 2012, PloS one.
[7] R. Salunga,et al. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. , 2011, The Journal of molecular diagnostics : JMD.
[8] G. Tseng,et al. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature. , 2011, Archives of pathology & laboratory medicine.
[9] J. Hogue,et al. Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up , 2011, Breast Cancer Research and Treatment.
[10] W. Woodward,et al. Population‐based analysis of occult primary breast cancer with axillary lymph node metastasis , 2010, Cancer.
[11] E. Maunsell,et al. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling , 2009, Breast Cancer Research and Treatment.
[12] R. Salunga,et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. , 2009, Archives of pathology & laboratory medicine.
[13] W. Gerald,et al. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations , 2005, Modern Pathology.
[14] E. Grabbe,et al. MRI of the breast in patients with metastatic disease of unknown primary , 1999, European Radiology.
[15] D. Lookingbill,et al. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. , 1993, Journal of the American Academy of Dermatology.